{
    "body": "Is cytisine superior to nicotine replacement therapy for smoking cessation?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22513936", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21154363", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17130378", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24574554", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25517706", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17825502", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24831822", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21328282", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22104038", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18076335", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17220536", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21385905", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18646137", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20040957", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23834141", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23404838", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17253581", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23978314", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23728690"
    ], 
    "ideal_answer": [
        "Yes, one clinical trial that directly compared smoking cessation rates with cytisine versus nicotine replacement therapy reported that cytisine was  superior to nicotine-replacement therapy in helping smokers quit smoking, but it was associated with a higher frequency of self-reported adverse events."
    ], 
    "exact_answer": "yes", 
    "concepts": [
        "http://www.biosemantics.org/jochem#4273701", 
        "http://www.biosemantics.org/jochem#4251343"
    ], 
    "type": "yesno", 
    "id": "54d77f0e3706e8952800001b", 
    "snippets": [
        {
            "offsetInBeginSection": 1245, 
            "offsetInEndSection": 1541, 
            "text": "The effectiveness of cytisine for continuous abstinence was superior to that of nicotine-replacement therapy at 1 week, 2 months, and 6 months. In a prespecified subgroup analysis of the primary outcome, cytisine was superior to nicotine-replacement therapy among women and noninferior among men.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25517706", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1833, 
            "offsetInEndSection": 2068, 
            "text": "CONCLUSIONS: When combined with brief behavioral support, cytisine was found to be superior to nicotine-replacement therapy in helping smokers quit smoking, but it was associated with a higher frequency of self-reported adverse events.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25517706", 
            "endSection": "abstract"
        }
    ]
}